Our top pick for
VIZIO Holding Corp is a consumer electronics business based in the US. VIZIO Holding shares (VZIO) are listed on the NYSE and all prices are listed in US Dollars. VIZIO Holding employs 527 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$20.12|
|52-week range||$17.25 - $28.80|
|50-day moving average||$19.80|
|200-day moving average||$22.47|
|Wall St. target price||$29.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.31|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||4.96%|
|1 month (2021-09-24)||2.86%|
|3 months (2021-07-23)||-22.85%|
|6 months (2021-04-23)||-12.48%|
|1 year (2020-10-20)||N/A|
|2 years (2019-10-20)||N/A|
|3 years (2018-10-20)||N/A|
|5 years (2016-10-20)||N/A|
Valuing VIZIO Holding stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of VIZIO Holding's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
VIZIO Holding's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 61x. In other words, VIZIO Holding shares trade at around 61x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
However, VIZIO Holding's P/E ratio is best considered in relation to those of others within the consumer electronics industry or those of similar companies.
VIZIO Holding's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $104.5 million.
The EBITDA is a measure of a VIZIO Holding's overall financial performance and is widely used to measure a its profitability.
To put VIZIO Holding's EBITDA into context you can compare it against that of similar companies.
|Revenue TTM||$2.2 billion|
|Operating margin TTM||4.65%|
|Gross profit TTM||$296.4 million|
|Return on assets TTM||11.3%|
|Return on equity TTM||107.69%|
|Market capitalisation||$3.5 billion|
TTM: trailing 12 months
There are currently 4.1 million VIZIO Holding shares held short by investors – that's known as VIZIO Holding's "short interest". This figure is 5.2% up from 3.9 million last month.
There are a few different ways that this level of interest in shorting VIZIO Holding shares can be evaluated.
VIZIO Holding's "short interest ratio" (SIR) is the quantity of VIZIO Holding shares currently shorted divided by the average quantity of VIZIO Holding shares traded daily (recently around 1.1 million). VIZIO Holding's SIR currently stands at 3.87. In other words for every 100,000 VIZIO Holding shares traded daily on the market, roughly 3870 shares are currently held short.
To gain some more context, you can compare VIZIO Holding's short interest ratio against those of similar companies.
However VIZIO Holding's short interest can also be evaluated against the total number of VIZIO Holding shares, or, against the total number of tradable VIZIO Holding shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case VIZIO Holding's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 VIZIO Holding shares in existence, roughly 20 shares are currently held short) or 0.2199% of the tradable shares (for every 100,000 tradable VIZIO Holding shares, roughly 220 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against VIZIO Holding.
Find out more about how you can short VIZIO Holding stock.
We're not expecting VIZIO Holding to pay a dividend over the next 12 months.
VIZIO Holding Corp. , through its subsidiaries, provides smart televisions, sound bars, and accessories in the United States. It also operates Platform+ that comprises SmartCast, a Smart TV operating system, enabling integrated home entertainment solution, and data intelligence and services products through Inscape. Its SmartCast delivers content and applications through an easy-to-use interface, as well as supports streaming apps and hosts its free ad-supported video app, WatchFree, and VIZIO Free Channels. In addition, the company provides support for third-party voice platforms. It sells its products to retailers and through online channels. The company was incorporated in 2002 and is headquartered in Irvine, California.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.